| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.34 | 0.0005 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0006 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0008 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0009 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.27 | 0.001 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.001 |